Literature DB >> 34006994

Non-alcoholic fatty liver disease in obese children and adolescents: a role for nutrition?

Luisa Bonsembiante1, Giovanni Targher2, Claudio Maffeis3.   

Abstract

Non-alcoholic fatty liver disease (NAFLD) has become the most common cause of chronic liver disease in children, paralleling the increasing prevalence of obesity worldwide. The pathogenesis of paediatric NAFLD is not fully understood, but it is known that obesity, nutrition, lifestyle variables, genetic and epigenetic factors may be causally involved in the development of this common metabolic liver disease. In particular, obesity and nutrition are among the strongest risk factors for paediatric NAFLD, which may exert their adverse hepatic effects already before birth. Excess energy intake induces hypertrophy and hyperplasia of adipose tissue with subsequent development of systemic insulin resistance, which is another important risk factor for NAFLD. Diet composition and in particular simple carbohydrate intake (especially high fructose intake) may promote the development of NAFLD, whereas non-digestible carbohydrates (dietary fiber), by affecting gut microbiota, may favour the integrity of gut wall and reduce inflammation, opposing this process. Saturated fat intake may also promote NAFLD development, whereas unsaturated fat intake has some beneficial effects. Protein intake does not seem to affect the development of NAFLD, but further investigation is needed. In conclusion, lifestyle modifications to induce weight loss, through diet and physical activity, remain the mainstay of treatment for paediatric NAFLD. The use of dietary supplements, such as omega-3 fatty acids and probiotics, needs further study before recommendation.
© 2021. The Author(s), under exclusive licence to Springer Nature Limited.

Entities:  

Mesh:

Year:  2021        PMID: 34006994     DOI: 10.1038/s41430-021-00928-z

Source DB:  PubMed          Journal:  Eur J Clin Nutr        ISSN: 0954-3007            Impact factor:   4.016


  87 in total

1.  Histopathology of pediatric nonalcoholic fatty liver disease.

Authors:  Jeffrey B Schwimmer; Cynthia Behling; Robert Newbury; Reena Deutsch; Caroline Nievergelt; Nicholas J Schork; Joel E Lavine
Journal:  Hepatology       Date:  2005-09       Impact factor: 17.425

2.  Methods to improve the noninvasive diagnosis and assessment of disease severity in children with suspected nonalcoholic fatty liver disease (NAFLD): Study design.

Authors:  Bryan Rudolph; Nicole Bjorklund; Nadia Ovchinsky; Debora Kogan-Liberman; Adriana Perez; Mark Liszewski; Terry L Levin; Michelle Ewart; Qiang Liu; Xiaonan Xue; Shankar Viswanathan; Howard D Strickler
Journal:  Contemp Clin Trials       Date:  2018-10-27       Impact factor: 2.226

Review 3.  The Global Syndemic of Obesity, Undernutrition, and Climate Change: The Lancet Commission report.

Authors:  Boyd A Swinburn; Vivica I Kraak; Steven Allender; Vincent J Atkins; Phillip I Baker; Jessica R Bogard; Hannah Brinsden; Alejandro Calvillo; Olivier De Schutter; Raji Devarajan; Majid Ezzati; Sharon Friel; Shifalika Goenka; Ross A Hammond; Gerard Hastings; Corinna Hawkes; Mario Herrero; Peter S Hovmand; Mark Howden; Lindsay M Jaacks; Ariadne B Kapetanaki; Matt Kasman; Harriet V Kuhnlein; Shiriki K Kumanyika; Bagher Larijani; Tim Lobstein; Michael W Long; Victor K R Matsudo; Susanna D H Mills; Gareth Morgan; Alexandra Morshed; Patricia M Nece; An Pan; David W Patterson; Gary Sacks; Meera Shekar; Geoff L Simmons; Warren Smit; Ali Tootee; Stefanie Vandevijvere; Wilma E Waterlander; Luke Wolfenden; William H Dietz
Journal:  Lancet       Date:  2019-01-27       Impact factor: 79.321

Review 4.  Predicting adult obesity from childhood obesity: a systematic review and meta-analysis.

Authors:  M Simmonds; A Llewellyn; C G Owen; N Woolacott
Journal:  Obes Rev       Date:  2015-12-23       Impact factor: 9.213

Review 5.  Global Perspectives on Nonalcoholic Fatty Liver Disease and Nonalcoholic Steatohepatitis.

Authors:  Zobair Younossi; Frank Tacke; Marco Arrese; Barjesh Chander Sharma; Ibrahim Mostafa; Elisabetta Bugianesi; Vincent Wai-Sun Wong; Yusuf Yilmaz; Jacob George; Jiangao Fan; Miriam B Vos
Journal:  Hepatology       Date:  2019-06       Impact factor: 17.425

6.  Preclinical signs of liver and cardiac damage in youth with metabolically healthy obese phenotype.

Authors:  P Di Bonito; E Miraglia Del Giudice; C Chiesa; M R Licenziati; M Manco; F Franco; G Tornese; M G Baroni; A Morandi; C Maffeis; L Pacifico; G Valerio
Journal:  Nutr Metab Cardiovasc Dis       Date:  2018-09-04       Impact factor: 4.222

7.  The natural history of non-alcoholic fatty liver disease in children: a follow-up study for up to 20 years.

Authors:  A E Feldstein; P Charatcharoenwitthaya; S Treeprasertsuk; J T Benson; F B Enders; P Angulo
Journal:  Gut       Date:  2009-07-21       Impact factor: 23.059

8.  Body-Mass Index in 2.3 Million Adolescents and Cardiovascular Death in Adulthood.

Authors:  Gilad Twig; Gal Yaniv; Hagai Levine; Adi Leiba; Nehama Goldberger; Estela Derazne; Dana Ben-Ami Shor; Dorit Tzur; Arnon Afek; Ari Shamiss; Ziona Haklai; Jeremy D Kark
Journal:  N Engl J Med       Date:  2016-04-13       Impact factor: 91.245

Review 9.  NAFLD in children: new genes, new diagnostic modalities and new drugs.

Authors:  Valerio Nobili; Anna Alisi; Luca Valenti; Luca Miele; Ariel E Feldstein; Naim Alkhouri
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2019-07-05       Impact factor: 46.802

Review 10.  Pediatric non-alcoholic fatty liver disease: Recent solutions, unresolved issues, and future research directions.

Authors:  Maria Grazia Clemente; Claudia Mandato; Marco Poeta; Pietro Vajro
Journal:  World J Gastroenterol       Date:  2016-09-28       Impact factor: 5.742

View more
  4 in total

Review 1.  Advances in pediatric non-alcoholic fatty liver disease: From genetics to lipidomics.

Authors:  Simona Riccio; Rosa Melone; Caterina Vitulano; Pierfrancesco Guida; Ivan Maddaluno; Stefano Guarino; Pierluigi Marzuillo; Emanuele Miraglia Del Giudice; Anna Di Sessa
Journal:  World J Clin Pediatr       Date:  2022-03-23

2.  Hepatoprotective Effects of Ixeris chinensis on Nonalcoholic Fatty Liver Disease Induced by High-Fat Diet in Mice: An Integrated Gut Microbiota and Metabolomic Analysis.

Authors:  Wenjie Jin; Sungbo Cho; Namujila Laxi; Terigele Bao; Lili Dai; Hongzhen Yu; Rigeer Qi; Junqing Zhang; Genna Ba; Minghai Fu
Journal:  Molecules       Date:  2022-05-14       Impact factor: 4.927

Review 3.  The Role of Macronutrients in the Pathogenesis, Prevention and Treatment of Non-Alcoholic Fatty Liver Disease (NAFLD) in the Paediatric Population-A Review.

Authors:  Thomas Pixner; Nathalie Stummer; Anna Maria Schneider; Andreas Lukas; Karin Gramlinger; Valérie Julian; David Thivel; Katharina Mörwald; Katharina Maruszczak; Harald Mangge; Julian Gomahr; Daniel Weghuber; Dieter Furthner
Journal:  Life (Basel)       Date:  2022-06-05

Review 4.  The Role of Fatty Acids in Non-Alcoholic Fatty Liver Disease Progression: An Update.

Authors:  Aleksandra Hliwa; Bruno Ramos-Molina; Dariusz Laski; Adriana Mika; Tomasz Sledzinski
Journal:  Int J Mol Sci       Date:  2021-06-27       Impact factor: 5.923

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.